Trial Profile
A Study to Evaluate the Efficacy of Bicalutamide With Dose Escalated External Beam Radiotherapy (DE-EBRT) versus DE-EBRT in Patients With Localized Prostate Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2016
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 23 Jun 2016 New trial record
- 24 May 2016 Primary endpoint has not been met. (Biochemical failure incidence), as per results published in the Cancer.
- 24 May 2016 Results published in the Cancer